MELISSA KIM: Open Payments
NPI 1326559568 · PEORIA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,151 in 109 payments from 21 companies in 2025. Trend: 2023 $4,924 · 2024 $5,264 · 2025 $4,151
Food & beverage: $3,968Education: $183
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 13 | $826 |
| Janssen Biotech, Inc. | 11 | $723 |
| Lilly USA, LLC | 11 | $369 |
| Gilead Sciences, Inc. | 11 | $344 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $295 |
| QOL Medical, LLC | 7 | $237 |
| ABBVIE INC. | 13 | $231 |
| Regeneron Healthcare Solutions, Inc. | 4 | $213 |
| GENZYME CORPORATION | 8 | $213 |
| Phathom Pharmaceuticals, Inc. | 3 | $169 |
Products named: REZDIFFRA, TREMFYA, DUPIXENT, OMVOH, ENTYVIO, Sucraid, VOQUEZNA, Epclusa.
Industry payments across AZ — which companies pay providers there.
